Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot study
- 1 August 1985
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 152 (8), 1034-1038
- https://doi.org/10.1016/0002-9378(85)90554-x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary reportFertility and Sterility, 1984
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983
- Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (d-Ser[TBU]6-des-Gly-NH210) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal womenFertility and Sterility, 1982